A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation
International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (10)
DOI: 10.25258/ijpqa.16.10.81 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Vikash Gaurav.
Abstract (Originalsprache)
Background: “ Laryngoscopy and tracheal intubation trigger sympathetic responses, causing transient elevations in heart rate and blood pressure, which may be hazardous in patients with cardiovascular risk. Beta-blockers such as esmolol and labetalol are commonly used to attenuate these hemodynamic responses.
Aim
To compare the efficacy of intravenous esmolol and labetalol in blunting the hemodynamic response during laryngoscopy and tracheal intubation in adult patients undergoing elective surgery. Methodology: A prospective, hospital-based, comparative observational study was conducted on 90 ASA I–II adult patients, randomized to receive esmolol (0.5 mg/kg, n=45) or labetalol (0.25 mg/kg, n=45) before intubation. Hemodynamic parameters—heart rate, diastolic blood pressure, and rate pressure product—were recorded at baseline, post-induction, intubation, and at 1, 3-, 5-, 10-, and 15-minutes post-intubation.
Results
Baseline parameters were comparable between groups. Labetalol produced significantly lower heart rates, diastolic pressures, and rate pressure product than esmolol at most time points, indicating superior attenuation of cardiovascular stress. A transient 3–5-minute window showed comparable efficacy.
Conclusion
Intravenous labetalol (0.25 mg/kg) provides more sustained hemodynamic stability than esmolol (0.5 mg/kg) during laryngoscopy and intubation, making it the preferred agent for peri-intubation cardiovascular protection
Zitieren
APA
Gaurav, V. (2026). A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation. International Journal of Pharmaceutical Quality Assurance, 16(10). https://doi.org/10.25258/ijpqa.16.10.81
Vancouver
Gaurav V. A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation. International Journal of Pharmaceutical Quality Assurance. 2026;16(10). doi:10.25258/ijpqa.16.10.81
BibTeX
@article{Gaurav2026,
author = {Gaurav, Vikash},
title = {A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {10},
doi = {10.25258/ijpqa.16.10.81}
}
EUVIMED